Growing awareness of vitamin D deficiency is a key driver in the market. Public health campaigns and educational initiatives have emphasized the importance of maintaining adequate vitamin D levels for overall health, including bone health, immune function, and the prevention of chronic conditions.
Additionally, the global population is aging, particularly in developed countries, and older adults are more prone to vitamin D deficiency due to reduced skin synthesis and less time spent outdoors.
This demographic shift increases the demand for vitamin D therapy as older individuals seek to maintain bone density, muscle strength, and overall well-being. Additionally, older adults are more likely to have chronic conditions such as osteoporosis, which further drives the demand for vitamin D therapy.
Further, the availability of over-the-counter drugs (OTC) vitamin D makes it easy for consumers to access therapy without a prescription. This ease of access and affordability of OTC vitamin D supplements contribute significantly to market growth, as more people can take proactive steps to manage their vitamin D levels.
Authors:
Mariam Faizullabhoy, Gauri Wani
Frequently Asked Questions (FAQ) :
The global vitamin D therapy market size was valued at USD 2.9 billion in 2023 and is anticipated to showcase growth at 11.4% CAGR from 2024 – 2032, due to increasing awareness of vitamin D deficiency and its health benefits across all age groups.
The OTC drugs segment accounted 58.7% of the market share in 2023, due to its accessibility and convenience for consumers.
North America vitamin D therapy market accounted for 41.3% revenue share in 2023 and is predicted to reach USD 3 billion by 2032, owing to high prevalence of vitamin D deficiency and aging population.